Effects of ERK1/2/PPARα/SCAD signal pathways on cardiomyocyte hypertrophy induced by insulin-like growth factor 1 and phenylephrine
- 1 March 2015
- journal article
- Published by Elsevier in Life Sciences
- Vol. 124, 41-49
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81000072)
- Fund for Emphasis on Cultivating Young Teachers
This publication has 30 references indexed in Scilit:
- Resveratrol prevents pathological but not physiological cardiac hypertrophyJournal of Molecular Medicine, 2014
- A 24-HOUR AMBULATORY ECG MONITORING IN ASSESSMENT OF QT INTERVAL DURATION AND DISPERSION IN ROWERS WITH PHYSIOLOGICAL MYOCARDIAL HYPERTROPHYBiology of Sport, 2013
- Left Ventricular Dysfunction Assessed by Cardiac Time Interval Analysis Among Different Geometric Patterns in Untreated HypertensionCirculation Journal, 2012
- Sex differences in physiological cardiac hypertrophy are associated with exercise-mediated changes in energy substrate availabilityAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- The Athlete's Heart vs. the Failing Heart: Can Signaling Explain the Two Distinct Outcomes?Physiology, 2011
- Glucose metabolism and cardiac hypertrophyCardiovascular Research, 2011
- Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overloadCardiovascular Research, 2009
- Left ventricular systolic function is abnormal in diastolic heart failure: Re-assessment of systolic function using cardiac time interval analysisJournal of Cardiology, 2009
- Controversies in ventricular remodellingThe Lancet, 2006
- Skeletal Muscle Lipid Metabolism in Exercise and Insulin ResistancePhysiological Reviews, 2006